7 Reasons Phosphatidylserine Deserves a Closer Look in Menopause
The brain fog and the 3am cortisol spiral felt like two separate problems for a long time — the kind where you lie awake catastrophising and then spend the next day forgetting words. Finding out there was a compound that specifically targets both the HPA stress axis and memory consolidation felt almost too neat. It is not a magic fix, but it is one of the more coherent pieces of the puzzle.
Learn more about Rose →It Directly Blunts the Cortisol Spike That Wakes Women at 3am
Phosphatidylserine acts on the hypothalamic-pituitary-adrenal (HPA) axis — the same stress-response system that goes haywire in perimenopause as oestrogen declines and loses its dampening effect on cortisol. Multiple randomised trials have shown that supplemental phosphatidylserine (typically 400–800mg daily) significantly reduces ACTH and cortisol responses to both physical and psychological stress. For women whose night wakings are driven by a cortisol surge in the early morning hours rather than hot flushes, this mechanism is directly relevant.
It Is One of the Brain's Own Structural Building Blocks
Phosphatidylserine is not an external compound the body has to adapt to — it is a phospholipid that makes up roughly 15% of total brain phospholipid content and is heavily concentrated in the inner leaflet of neuronal cell membranes. It plays an essential role in cell-to-cell signalling, neurotransmitter release, and the integrity of synaptic connections. Supplementing it essentially replenishes something the ageing brain is already losing, which is a different proposition from introducing a foreign active compound.
Clinical Trials Show Measurable Improvements in Memory and Learning
A body of placebo-controlled trials — including a notable series funded independently of supplement manufacturers — found that phosphatidylserine supplementation improved verbal memory, delayed recall, and learning tasks in adults experiencing age-associated memory impairment. The effect sizes are modest but consistent, and they appear most pronounced in people who already show early cognitive decline rather than those with normal baseline function. Women in midlife who notice the specific pattern of struggling to retrieve words or retain new information may sit squarely in that responsive group.
It Supports the Glucose Metabolism That Fuels an Oestrogen-Deprived Brain
Oestrogen plays a significant role in how the brain metabolises glucose, and declining oestrogen in perimenopause is associated with reduced cerebral glucose uptake — a change that neuroimaging research has linked to early cognitive symptoms. Phosphatidylserine has been shown in PET studies to partially restore cerebral glucose metabolism in people with memory complaints, which maps directly onto the mechanism underlying menopausal brain fog. This is not the same as treating dementia, but it addresses a real and measurable metabolic shift happening in the perimenopausal brain.
It May Reduce the Subjective Experience of Psychological Stress
Beyond measurable cortisol reduction, several trials have assessed mood and psychological stress outcomes alongside hormonal markers, and found that participants reported feeling less stressed and less emotionally reactive under conditions of chronic moderate stress — the kind that characterises most women's perimenopause experience rather than acute trauma. The proposed mechanism involves phosphatidylserine's role in modulating dopaminergic and serotonergic neurotransmission, both of which are also affected by falling oestrogen. It is not an antidepressant, and it should not be positioned as one, but the mood-adjacent effects appear to be a genuine secondary benefit.
Combining It With DHA Appears to Amplify the Cognitive Effects
Phosphatidylserine and DHA (docosahexaenoic acid, the omega-3 found in oily fish) appear to have a synergistic relationship in the brain — DHA is the fatty acid most commonly esterified to phosphatidylserine in neural tissue, and several studies suggest the combination outperforms either compound alone on memory outcomes. This is physiologically logical: DHA provides the structural fluidity of the membrane while phosphatidylserine governs the signalling scaffold. Women already taking omega-3s may find that adding phosphatidylserine produces a more noticeable effect than if they were starting from scratch.
It Has a Strong Safety Record With Few Meaningful Drug Interactions
Phosphatidylserine has been assessed in multiple safety reviews and carries a Generally Recognized as Safe (GRAS) designation from the FDA for soy-derived forms, with no serious adverse events reported in clinical trials at doses up to 800mg daily. The only interaction worth noting is a theoretical additive effect with anticoagulants due to its influence on membrane-bound clotting factors, so women on blood thinners should flag it with their prescriber. For a compound with this level of mechanistic relevance to perimenopause, that is a relatively clean risk profile — though as with any supplement, it is worth discussing with a healthcare provider before starting.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.